The "Immunotherapy in Oncology Patent Landscape Report and Forecast 2024-2032" report has been added to ...

Asthma inhalers are one type of allergic asthma medication that can help when symptoms begin. Find out which other types of ...

It delves into patent filing trends, highlighting key players and their contributions to advancing immunotherapy. The report identifies emerging therapeutic targets and assesses the competitive ...

Versamune ® is a registered trademark of PDS Biotechnology Corporation. Investor Contact: Mike Moyer LifeSci Advisors Phone +1 (617) 308-4306 Email: mmoyer@lifesciadvisors.com ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...

Researchers have discovered a new approach to prostate cancer treatment by combining immunotherapy with PIM1 kinase ...

Certain proteins in cerebrospinal fluid could act as key indicators for a harmful side effect of cancer immunotherapy, ...

Bristol-Myers Squibb has announced a definitive agreement to acquire biotechnology company 2seventy bio for $5.00 per share ...

Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs.